{"id":"https://openalex.org/W7100428010","doi":null,"title":"New InsulinGlargine 300Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2) Diabetes Care 2014;37:3235\u20133243 | DOI: 1","display_name":"New InsulinGlargine 300Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2) Diabetes Care 2014;37:3235\u20133243 | DOI: 1","alternate_titles":[],"publication_year":null,"publication_date":null,"ids":{"openalex":"https://openalex.org/W7100428010"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.997.1067","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.997.1067","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://care.diabetesjournals.org/content/diacare/37/12/3235.full.pdf","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7100428010"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5497999787330627,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5497999787330627,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.44530001282691956,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9129999876022339},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.9760000109672546},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.9089999794960022},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8500000238418579},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9769999980926514},{"id":"https://openalex.org/keywords/nocturnal-hypoglycemia","display_name":"nocturnal hypoglycemia","score":0.9330000281333923},{"id":"https://openalex.org/keywords/severe-hypoglycemia","display_name":"severe hypoglycemia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.7599999904632568},{"id":"https://openalex.org/keywords/insulin-dose-reduction","display_name":"insulin dose reduction","score":0.5429999828338623},{"id":"https://openalex.org/keywords/long-acting-insulin","display_name":"long-acting insulin","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8967999815940857},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.8831999897956848},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.7368000149726868},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.701200008392334},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6802999973297119},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.6751999855041504},{"id":"https://openalex.org/C2778024521","wikidata":"https://www.wikidata.org/wiki/Q55639806","display_name":"Basal (medicine)","level":3,"score":0.5741999745368958},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5604000091552734},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5037000179290771},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4999000132083893},{"id":"https://openalex.org/C2909524832","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Basal insulin","level":4,"score":0.4683000147342682},{"id":"https://openalex.org/C2777334680","wikidata":"https://www.wikidata.org/wiki/Q1607611","display_name":"Nocturnal","level":2,"score":0.43549999594688416},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.39730000495910645},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3474999964237213},{"id":"https://openalex.org/C2778537899","wikidata":"https://www.wikidata.org/wiki/Q254034","display_name":"Bedtime","level":2,"score":0.3345000147819519},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.28040000796318054},{"id":"https://openalex.org/C2987804222","wikidata":"https://www.wikidata.org/wiki/Q5376582","display_name":"End point","level":2,"score":0.2782999873161316},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.26899999380111694},{"id":"https://openalex.org/C2780320433","wikidata":"https://www.wikidata.org/wiki/Q3403879","display_name":"Weight gain","level":3,"score":0.2653000056743622}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.997.1067","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.997.1067","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://care.diabetesjournals.org/content/diacare/37/12/3235.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4230570152","https://openalex.org/W2100633491","https://openalex.org/W7098691607","https://openalex.org/W1726580060","https://openalex.org/W2255382886","https://openalex.org/W2139040359","https://openalex.org/W2333730597","https://openalex.org/W2335147656","https://openalex.org/W2315702610"],"abstract_inverted_index":{"To":[0],"compare":[1],"the":[2,193,209,249,256],"efficacy":[3],"and":[4,114,191,199,240,251],"safety":[5,229],"of":[6,78,110,116,159,246,255],"new":[7],"insulin":[8,26,49],"glargine":[9,14],"300":[10],"units/mL":[11,16],"(Gla-300)":[12],"with":[13,20,80,124,154,173,217,220,242],"100":[15],"(Gla-100)":[17],"in":[18,69,228],"people":[19],"type":[21],"2":[22,39],"diabetes":[23],"using":[24],"basal":[25,48,126],"(\u202142":[27],"units/day)":[28],"plus":[29,50],"oral":[30],"antihyperglycemic":[31],"drugs":[32],"(OADs).":[33],"RESEARCH":[34],"DESIGN":[35],"AND":[36],"METHODS":[37],"EDITION":[38],"was":[40,67,76,135,171,215,235],"a":[41,243],"multicenter,":[42],"open-label,":[43],"two-arm":[44],"study.":[45],"Adults":[46],"receiving":[47],"OADs":[51],"were":[52,206,231],"randomized":[53],"to":[54,97,152,178],"Gla-300":[55,140,174,218,234],"or":[56,82,90,168],"Gla-100":[57,145,221,239],"once":[58],"daily":[59],"for":[60,139,144],"6":[61,180],"months.":[62],"The":[63,71],"primary":[64],"end":[65,74],"point":[66,75],"change":[68],"HbA1c.":[70],"main":[72],"secondary":[73],"percentage":[77],"participants":[79,102],"one":[81],"more":[83],"nocturnal":[84,162,198],"confirmed":[85,163],"(\u00a33.9":[86,164],"mmol/L":[87,165],"[\u00a370":[88,166],"mg/dL])":[89,167],"severe":[91,169],"hypoglycemic":[92,204],"events":[93,205],"from":[94,133,175],"week":[95,176],"9":[96,177],"month":[98,179],"6.":[99],"RESULTS":[100],"Randomized":[101],"(n":[103],"=":[104,189,223],"811)":[105],"had":[106],"amean":[107],"(SD)":[108,131],"HbA1c":[109],"8.24":[111],"%":[112,137,142,148,150,156,185],"(0.82)":[113],"BMI":[115],"34.8":[117],"kg/m2":[118],"(6.4).":[119],"Glycemic":[120],"control":[121],"improved":[122],"similarly":[123],"both":[125],"insulins;":[127],"least":[128],"squares":[129],"mean":[130],"reduction":[132],"baseline":[134],"20.57":[136],"(0.09)":[138,143],"and20.56":[141],"(mean":[146],"difference20.01":[147],"[95":[149,184],"CI20.14":[151],"0.12]),":[153],"10":[155],"higher":[157],"dose":[158],"Gla-300.":[160],"Less":[161],"hypoglycemia":[170],"observed":[172],"(relative":[181],"risk":[182,245],"0.77":[183],"CI":[186],"0.61\u20130.99];":[187],"P":[188],"0.038)":[190],"during":[192,208,248],"first":[194],"8":[195],"weeks.":[196],"Fewer":[197],"any":[200,253],"time":[201,254],"(24":[202],"h)":[203],"reported":[207],"entire":[210],"6-month":[211],"period.":[212],"Weight":[213],"gain":[214],"lower":[216,244],"than":[219],"(P":[222],"0.015).":[224],"No":[225],"between-treatment":[226],"differences":[227],"parameters":[230],"identified.":[232],"CONCLUSIONS":[233],"as":[236,238],"effective":[237],"associated":[241],"hypogly-cemia":[247],"night":[250],"at":[252],"day.":[257]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7100428010","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2025-10-27T00:00:00"}
